small molecule

RIZAFILM

RIZATRIPTAN BENZOATE

Loss of exclusivityJuly 2034latest FDA-listed patent expiry
CompanyGENSCO LABORATORIES LLC DBA GENSCO PHARMA

Drug detail

Brand nameRIZAFILM
Active ingredientRIZATRIPTAN BENZOATE
StrengthEQ 5MG BASE
Dosage formFILM
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2026
Marketing statusDISCN

Listed patents

PatentExpiresType
9301948July 2034product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.